Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (211-220 of 251) with videos related to

Pageof 26
Sort By:
Cancer Treatment Reports|December 1, 1977
Phase II study of cytosine arabinoside in advanced large bowel cancerS A Cullinan, M J O'Connell, C G Moertel, et al.
Annals of Internal Medicine|February 15, 1994
The management of patients with advanced carcinoid tumors and islet cell carcinomasC G Moertel, C M Johnson, M A McKusick, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1992
Carcinoid disease of the heart. Surgical management of ten patientsC J Knott-Craig, H V Schaff, C J Mullany, et al.
Annals of Neurology|March 1, 1992
Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisoleC C Hook, D W Kimmel, L K Kvols, et al.
The New England Journal of Medicine|November 13, 1986
Survival after postoperative combination treatment of rectal cancerH O Douglass, C G Moertel, R J Mayer, et al.
Cancer|October 1, 1988
Hepatoma in the noncirrhotic liverS R Smalley, C G Moertel, J F Hilton, et al.
Cancer|July 1, 1984
Carcinoma of the anal canal. A clinical and pathologic study of 188 casesB M Boman, C G Moertel, M J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group studyJ H Donohue, S Williams, S Cha, et al.
Cancer|August 1, 1975
The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancerT P Waalkes, C W Gehrke, R W Zumwalt, et al.
Cancer|September 15, 1995
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo ClinicR M Goldberg, C G Moertel, H S Wieand, et al.
Pageof 26

Showing results (211-220 of 251) with videos related to

Sort By:
Pageof 26
Cancer Treatment Reports|December 1, 1977
Phase II study of cytosine arabinoside in advanced large bowel cancerS A Cullinan, M J O'Connell, C G Moertel, et al.
Annals of Internal Medicine|February 15, 1994
The management of patients with advanced carcinoid tumors and islet cell carcinomasC G Moertel, C M Johnson, M A McKusick, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1992
Carcinoid disease of the heart. Surgical management of ten patientsC J Knott-Craig, H V Schaff, C J Mullany, et al.
Annals of Neurology|March 1, 1992
Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisoleC C Hook, D W Kimmel, L K Kvols, et al.
The New England Journal of Medicine|November 13, 1986
Survival after postoperative combination treatment of rectal cancerH O Douglass, C G Moertel, R J Mayer, et al.
Cancer|October 1, 1988
Hepatoma in the noncirrhotic liverS R Smalley, C G Moertel, J F Hilton, et al.
Cancer|July 1, 1984
Carcinoma of the anal canal. A clinical and pathologic study of 188 casesB M Boman, C G Moertel, M J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group studyJ H Donohue, S Williams, S Cha, et al.
Cancer|August 1, 1975
The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancerT P Waalkes, C W Gehrke, R W Zumwalt, et al.
Cancer|September 15, 1995
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo ClinicR M Goldberg, C G Moertel, H S Wieand, et al.
Pageof 26